Cannabinoid Therapy for Chronic Cervical and Lumbar Spine Pain
Direct Answer
I do not recommend adding cannabinoid therapy to this patient's regimen, as there is no guideline or high-quality evidence supporting its use for chronic spine pain, and the current polypharmacy includes several medications (diazepam, Norgesic) that lack evidence for chronic pain and should be discontinued first. 1
Critical Medication Review: Address Polypharmacy by Removing Ineffective Agents
Before adding any new therapy, you must rationalize the existing medication regimen by eliminating drugs with no evidence base:
Medications to Discontinue
Diazepam: Low-quality evidence shows diazepam provides no benefit for function, analgesic use, return to work, or likelihood of surgery in radicular pain, and actually resulted in lower likelihood of pain improvement at 1 week compared to placebo 1. This benzodiazepine contributes to polypharmacy without therapeutic benefit and carries significant risks in chronic pain patients.
Norgesic (orphenadrine/paracetamol/caffeine): There is no evidence supporting trigger point injections or muscle relaxants for chronic low back pain beyond 3 months 1. The caffeine component may actually block the analgesic effects of amitriptyline for neuropathic pain 2. Orphenadrine as a muscle relaxant has insufficient evidence for chronic spine pain 1.
Medications to Optimize
Amitriptyline: This has moderate evidence for neuropathic/radicular pain as a coanalgesic 1. Ensure dosing is adequate (50-150 mg nightly for pain, not the lower antidepressant doses) 1. Note that the caffeine in Norgesic may be antagonizing its analgesic effect 2.
Sertraline: SSRIs have moderate-quality evidence showing no difference in pain compared to placebo for chronic low back pain 1. Consider switching to duloxetine, which has moderate evidence for small improvements in pain intensity and function in chronic low back pain 1. Duloxetine dosing: start 30-60 mg daily, increase to 60-120 mg daily 1.
Evidence-Based Treatment Algorithm
Step 1: Optimize Conservative Multimodal Therapy (4-6 weeks minimum)
The 2025 BMJ guideline emphasizes that interventional procedures must be part of a comprehensive program including physical therapy, patient education, psychosocial support, and optimized oral medications 1, 3.
Medication optimization:
- Discontinue diazepam and Norgesic immediately 1
- Optimize amitriptyline to therapeutic analgesic dose (50-150 mg nightly) 1
- Consider switching sertraline to duloxetine 60-120 mg daily 1
- Add gabapentin (start 100-300 mg nightly, titrate to 900-3600 mg daily in divided doses) OR pregabalin (start 50 mg three times daily, increase to 100 mg three times daily) for neuropathic/radicular component 1
- Consider NSAIDs if not contraindicated (moderate evidence for small to moderate pain improvement) 1
Physical therapy:
- Must complete minimum 4-6 weeks of structured physical therapy before considering interventional procedures 1, 3
Step 2: Determine Pain Phenotype for Steroid Injection Candidacy
Critical distinction for injection appropriateness:
- Radicular pain (pain radiating below knee for lumbar, into arm distal to elbow for cervical): Moderate to strong evidence supports epidural steroid injections 3, 4, 5
- Axial spine pain only (back/neck pain without radiculopathy): Strong recommendation against epidural injections 1, 3. Consider radiofrequency ablation for facet-mediated pain instead 1, 3
Required documentation before injection:
- MRI within 24 months showing nerve root compression correlating with clinical symptoms 3
- Failed 4-6 weeks of optimized conservative therapy 1, 3
- Pain radiating below knee (lumbar) or distal to elbow (cervical) 3
Step 3: Steroid Injection Technique Selection (If Radicular Pain Present)
- Transforaminal approach: Moderate to strong evidence for radicular pain, but higher risk profile; must use fluoroscopic guidance 3, 5, 6
- Interlaminar approach: Strong evidence for short-term relief, moderate for long-term relief in lumbar radiculopathy 5
- Cervical epidural: Moderate evidence for cervical radiculopathy 4, 5, 6
Critical safety requirement: All epidural injections must be performed under fluoroscopic guidance 3
Why Cannabinoids Are Not Recommended
No guideline evidence exists supporting cannabinoid use for chronic spine pain. The provided guidelines from BMJ (2025), American College of Physicians (2017), Journal of Neurosurgery (2014), and Mayo Clinic (2010) make no mention of cannabinoids as a treatment option for chronic spine pain 1.
Rational polypharmacy reduction means:
- Remove medications with no evidence (diazepam, Norgesic) 1
- Optimize medications with evidence (amitriptyline, consider duloxetine) 1
- Add evidence-based coanalgesics (gabapentin or pregabalin) 1
- NOT adding unproven therapies like cannabinoids
Combination Therapy Evidence
Moderate evidence shows that combining gabapentin with extended-release morphine (or pregabalin with opioids) provides better pain relief at lower doses than either medication alone 1. The combination of nortriptyline and gabapentin was superior to either medication alone in neuropathic pain 1. A 2014 study showed combination therapy (epidural steroid injections plus nortriptyline/gabapentin plus physical therapy) provided better improvement than stand-alone treatments for cervical radicular pain 4.
Lisdexamfetamine Consideration
This stimulant is not mentioned in any chronic pain guidelines and raises concern for potential substance use disorder or inappropriate prescribing 1. Clarify the indication—if prescribed for ADHD, continue; if prescribed for pain or fatigue, this lacks evidence and should be reconsidered.
Common Pitfalls to Avoid
- Do not add cannabinoids without evidence when evidence-based medications (gabapentinoids, duloxetine) have not been tried 1
- Do not continue diazepam for chronic pain—it provides no benefit and increases harm 1
- Do not perform epidural injections for axial pain without radiculopathy—strong recommendation against this practice 1, 3
- Do not skip the 4-6 week conservative therapy trial before interventional procedures 1, 3
- Do not use caffeine-containing products (like Norgesic) with amitriptyline—caffeine blocks amitriptyline's analgesic effect 2